Literature DB >> 23838309

14q12 duplication including FOXG1: is there a common age-dependent epileptic phenotype?

Chiara Bertossi1, Matteo Cassina2, Luca De Palma1, Marilena Vecchi1, Sara Rossato3, Irene Toldo1, Marta Donà2, Alessandra Murgia1, Clementina Boniver1, Stefano Sartori4.   

Abstract

INTRODUCTION: Duplications of 14q12 encompassing FOXG1 gene have been recently associated with developmental delay, severe speech impairment, epilepsy, aspecific neuroimaging findings and minor dysmorphisms. AIM AND METHODS: In order to refine the epileptic phenotype associated with 14q12 duplications, we have performed a review of the electroclinical picture of the patients reported to date in the literature, adding a new personal case. A comprehensive set of clinical and instrumental data (with a particular focus on the electroclinical aspects including seizure type, age of onset, EEG at onset and after antiepileptic therapy, drug efficacy) has been taken into account.
RESULTS: 9/14 patients carrying 14q12 duplications developed seizures, all in the first months of life. Most of them developed infantile spasms (8/9 epileptic patients) and presented hypsarrhythmia or modified hypsarrhythmia on EEG. After therapy 5/9 patients became seizure free and 3/9 present a good seizure control. At last available follow up, 2/3 of the epileptic patients displayed an almost normal EEG, or a quite organized background activity, with diffuse or focal (mostly temporal) slowing.
CONCLUSIONS: The review of the available data allowed to recognize a common epileptic core, characterized by early onset, age dependent epileptic encephalopathy with infantile spasms and typical, atypical or modified hypsarrhythmia. Antiepileptic therapy soon led to a good or complete control of seizures with a nearly normal background activity in most patients.
Copyright © 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  14q12 duplication; Epileptic encephalopathy; FOXG1; Infantile spasms

Mesh:

Substances:

Year:  2013        PMID: 23838309     DOI: 10.1016/j.braindev.2013.06.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 2.  Autism spectrum disorder and epilepsy: Disorders with a shared biology.

Authors:  Bo Hoon Lee; Tristram Smith; Alex R Paciorkowski
Journal:  Epilepsy Behav       Date:  2015-04-19       Impact factor: 2.937

3.  Familial recurrences of FOXG1-related disorder: Evidence for mosaicism.

Authors:  Kelly Q McMahon; Apostolos Papandreou; Mandy Ma; Brenda J Barry; Ghayda M Mirzaa; William B Dobyns; Richard H Scott; Natalie Trump; Manju A Kurian; Alex R Paciorkowski
Journal:  Am J Med Genet A       Date:  2015-09-14       Impact factor: 2.802

4.  Epilepsy and outcome in FOXG1-related disorders.

Authors:  Laurie E Seltzer; Mandy Ma; Sohnee Ahmed; Mary Bertrand; William B Dobyns; James Wheless; Alex R Paciorkowski
Journal:  Epilepsia       Date:  2014-05-16       Impact factor: 5.864

5.  Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing.

Authors:  John Hoon Rim; Se Hee Kim; In Sik Hwang; Soon Sung Kwon; Jieun Kim; Hyun Woo Kim; Min Jung Cho; Ara Ko; Song Ee Youn; Jihun Kim; Young Mock Lee; Hee Jung Chung; Joon Soo Lee; Heung Dong Kim; Jong Rak Choi; Seung-Tae Lee; Hoon-Chul Kang
Journal:  BMC Med Genomics       Date:  2018-02-01       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.